GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

golimumab   Click here for help

GtoPdb Ligand ID: 6776

Synonyms: CNTO-148 | CNTO148 | Simponi®
Approved drug Immunopharmacology Ligand
golimumab is an approved drug (FDA (2009), EMA (2009))
Compound class: Antibody
Comment: TNFα inhibitor.
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: golimumab

Immunopharmacology Disease
Disease X-Refs Comment References
Psoriasis Disease Ontology: DOID:8893
 An anti-TNFα therapy approved for psoriasis.
Rheumatoid arthritis Disease Ontology: DOID:7148
OMIM: 180300
 An anti-TNFα therapy approved for RA.
Ulcerative colitis Disease Ontology: DOID:8577
OMIM: 266600
Orphanet: ORPHA771
 An anti-TNFα therapy approved for CD.
Ankylosing spondylitis Disease Ontology: DOID:7147
 An anti-TNFα therapy approved for ankylosing spondylitis.